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ABSTRACT
BACKGROUND AND PURPOSE: Intraplaque hemorrhage is considered a leading parameter of carotid plaque vulnerability. Our purpose
was to assess the CT characteristics of intraplaque hemorrhage with histopathologic correlation to identify features that allow for
confirming or ruling out the intraplaque hemorrhage.
MATERIALS ANDMETHODS: This retrospective study included 91 patients (67men; median age, 65 7 years; age range, 41–83 years) who
underwent CT angiography and carotid endarterectomy from March 2010 to May 2013. Histopathologic analysis was performed for the
tissue characterization and identification of intraplaque hemorrhage. Two observers assessed the plaque’s attenuation values by using an
ROI ( 1 and2 mm2). Receiver operating characteristic curve, Mann-Whitney, and Wilcoxon analyses were performed.
RESULTS: A total of 169 slices were assessed (59 intraplaque hemorrhage, 63 lipid-rich necrotic core, and 47 fibrous); the average values of
the intraplaque hemorrhage, lipid-rich necrotic core, and fibrous tissue were 17.475 Hounsfield units (HU) and 18.407 HU, 39.476 HU and
48.048 HU, and 91.66 HU and 93.128 HU, respectively, before and after the administration of contrast medium. The Mann-Whitney test
showed a statistically significant difference of HU values both in basal and after the administration of contrast material phase. Receiver
operating characteristic analysis showed a statistical association between intraplaque hemorrhage and low HU values, and a threshold of
25 HU demonstrated the presence of intraplaque hemorrhage with a sensitivity and specificity of 93.22% and 92.73%, respectively. The
Wilcoxon test showed that the attenuation of the plaque before and after administration of contrast material is different (intraplaque
hemorrhage, lipid-rich necrotic core, and fibrous tissue had P values of .006, .0001, and .018, respectively).
CONCLUSIONS: The results of this preliminary study suggest that CT can be used to identify the presence of intraplaque hemorrhage
according to the attenuation. A threshold of 25 HU in the volume acquired after the administration of contrast medium is associated with
an optimal sensitivity and specificity. Special care should be given to the correct identification of the ROI.
ABBREVIATIONS: Az area under the receiver operating characteristic curve; CEA carotid endarterectomy; HU Hounsfield unit; IPH intraplaque hemor-
rhage; LRNC lipid-rich necrotic core
During the past few years, several studies have demonstratedthat the occurrence of intraplaque hemorrhage (IPH) in the
carotid artery is linkedwith an increased risk of plaque rupture,1-3
and therefore, IPH is considered a fundamental parameter of the
so-called plaque vulnerability.4
Most of the research performed in the past 20 years was based
on results from autopsy studies or on the specimens taken from
carotid endartectomies.5,6 With the introduction of high-resolu-
tion black-blood MRI,7,8 it has become possible to identify non-
invasively the IPH with optimal correlation to histology, and past
literature has suggested an association between IPH and the oc-
currence of cerebrovascular events.9 In a recently publishedmeta-
analysis by Saam et al,10 it was demonstrated that the presence of
IPH is associated with a 5- to 7-fold higher risk of cerebrovascular
events.
However, carotid arteries are frequently imaged by using CT,
which allows for characterizing the degree of stenosis11,12 with an
excellent level of detail. Further, it offers information related to
the risk of the plaque vulnerability such as the volume of the
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plaque and it subcomponents13,14 or the identification of ulcers in
the plaque.15,16 Moreover, CT provides a unique option in some
categories of patients who cannot be imaged by usingMR imaging
(eg, those with a prosthesis or pacemaker). Therefore, the identi-
fication of the determinants of plaque vulnerability, and in par-
ticular IPH, could be extremely important.
The purpose of this study was to assess the CT characteristics
of the IPH with histopathologic correlation to identify features
that allow for confirming or ruling out the IPH.
MATERIALS AND METHODS
Study Design and Patient Population
The institutional review board of our hospital (Azienda Os-
pedaliera Universitaria di Cagliari) approved this retrospective
study protocol, and we included all the patients who under-
went carotid endarterectomy (CEA) and whose carotid speci-
men was analyzed by histologists. Therefore, 91 patients (67
men; median age, 65  7 years; age range, 41–83 years) who
underwent CEA from March 2010 to May 2013 were included.
This research was conducted in accordance with the guidelines
of our institution’s research committee, and because of the
retrospective nature of the analysis, patient consent was
waived.
We considered as an inclusion criterion that the CEA was per-
formed within 10 days after the CTA, whereas we excluded those
patients who underwent CEA for restenosis or radiation therapy–
induced carotid stenosis. A further exclusion criterion was the
plaque’s rupture or fragmentation during the CEA procedure
and/or manipulation.
In our hospital, the quantification of the degree of stenosis and
the carotid artery plaque analysis is performed by using CTA ac-
cording to previously published inclusion criteria.17,18 Carotid
sonography is used as the first-line technique to assess the pres-
ence of atherosclerosis, and briefly, CTA of carotid arteries is per-
formed when 1) carotid sonography shows a pathologic stenosis
( 50%measuredwith theNASCET criteria19) or features related
to plaque vulnerability (eg, ulcerations, irregular surface) and 2)
sonography cannot adequately assess the degree of stenosis and
the plaque’s characteristics because of anatomic conditions. Pa-
tients were also classified as symptomatic or asymptomatic ac-
cording to the neurologic assessment documented in the clinical
chart review by using the Trial of ORG 10172 in Acute Stroke
Treatment (TOAST) criteria. Part of the study population (n 
58) of this research was included in previously published
papers.20,21
CTA Technique
Patients were studied by using a 16–multidetector rowCT system
(Brilliance; Philips Healthcare, Best, the Netherlands). CT images
were obtained with coverage from the aortic arch to the carotid
siphon with caudocranial direction. Examinations were per-
formed before and after the administration of contrast material.
Angiographic phase was obtained with the administration of 80
mL of prewarmed contrast medium (Ultravist 370; Bayer Health-
Care, Berlin, Germany). CT technical parameters included: slice
thickness, 0.6 mm; interval, 0.3 mm; matrix size, 512 512; and
field of view, 14–19 cm. A C-filter algorithm of reconstruction
was applied.
Carotid Endarterectomy
Two vascular surgeons (R.M. and R.S., with 25 and 16 years of expe-
rience, respectively) performed all the CEA procedures by using the
“en-bloc” techniqueby scoring theoutermedia andadventitiawith a
scalpel and then removing the plaque as an intact tube. This ap-
proachwas adopted to reduce themanipulation of the carotid artery
and avoid the potential rupture/fragmentation of the plaque.
In our hospital, patients underwent CEA according to the rec-
ommendations by the Asymptomatic Carotid Atherosclerosis
Study (ACAS),22 NASCET,19 Stroke Prevention and Educational
Awareness Diffusion (SPREAD),23 and European Carotid Sur-
gery Trial (ECST)3 after the exclusion of a cardioembolic source
of embolism.
Histologic Analysis of the Plaque
The methods used for the plaque processing and histologic analysis
have been described in a previously published paper.20 In summary,
the histologic analysiswas performedby 2histologists (G.F. andL.L.,
with 22 and 5 years of experience, respectively) who were blinded to
the radiologic findings.After theCEA, theexcised“en-bloc”plaque is
immediately fixed in formalin, and it is sent to the laboratory directly
after the surgical procedure. Carotid plaques were decalcified and
embedded in paraffin wax. None of the CEA specimens showed dis-
ruptionof the luminal surface of the plaque. The portion of the spec-
imen that showed the carotid plaquewas divided transversely in sec-
tions having 3 mm intervals that were air-dried at 60°C for 45
minutes. After this phase, paraffin was removed by xylol, and the
sections were hydrated. Finally, endogenous peroxidase activity was
blocked by 2% hydrogen peroxide (H2O2). The transverse sections
were subjected to histologic examination to identify the plaque com-
ponents. Because themain focus of the study was to assess the atten-
uation characteristics of IPH, special care was used in the identifica-
tion of IPH. Finally, according to the histologic characteristics, the
plaque of each slice was categorized into one of 4 groups: IPH, lipid-
rich necrotic core (LRNC), fibrous, and calcified.
Co-Registration and Histology Matching
The co-registration between CTA and histologic slices represents
a key point of this paper, and special care was dedicated to avoid
misregistration. After the selection of the CTA slice, the corre-
sponding histologic section was identified by considering the fol-
lowing parameters: distance from the carotid bifurcation, lumen
shape, and presence of prominent areas of calcification. In partic-
ular, the location of the bifurcation was identified to measure the
length in the z-axis correctly. Moreover, given the difference in
thickness between the MDCTA image sections (0.625 mm) and
the histologic cross sections (5 m), to further validate, 2–3 his-
tologic sections were compared with 1 cross-sectional MDCTA
image on the basis of the relative distance from the bifurcation.
IPH and Plaque Analysis Quantification
Two radiologists (L.S. andM.F., with 11 and 8 years of experience
in CTA, respectively) performed all measurements of Hounsfield
units (HU) by using as window-level settings a width of 850 and
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length of 300.24 In this study, the registration phase between CT
and histologic slices was fundamental, and special care was used.
The CT analysis was performed in 3 different phases. The first one
was conducted with both radiologists in consensus to assess the
image quality of the datasets and exclude those carotid arteries
that showed dental streak artifacts or movement artifacts that re-
duced the image quality. The second and third phases were per-
formed with radiologists who worked independently.
In the second phase, the angiographic dataset was assessed;
radiologists had histopathologic sections as well as the spatial co-
ordinates (slice number – Z distance from the carotid bifurca-
tion), and they were asked to trace a circular or elliptical ROI (
1mm2 and2mm2) in the plaque and to quantify the HU atten-
uation values in the analyzed slice. The shape of the vessel wall and
the lumen as well as the location of the bifurcation and the pres-
ence of calcifications in the plaque were used for matching. The
procedures were repeated for each slice of each patient where it
was possible to trace an ROI of at least 1 mm2.
In the third phase, radiologists selected the basal scan dataset
and identified the same slice corresponding to the angiographic
phase. To reach a correct registration between basal and angio-
graphic datasets, they visually verified if the slices were registered
or if it was necessary to select another slice along the z-axis. After
this “matching phase,” the same ROI used in the contrast phase
(duplicate option) was positioned in the same position of the
plaque to measure the attenuation values (Fig 1).
Statistical Analysis
In this study, the normality of each continuous variable groupwas
tested by using the Kolmogorov-Smirnov Z test, and appropriate
tests for Gaussian or non-Gaussian values were selected. The
Bland-Altmanplotwas calculated between the 2 readers to test the
attenuation values, and the averaged value for each section was
considered for the analysis. The Mann-Whitney test was calcu-
lated to test the difference of attenuation values between the dif-
ferent categories (IPH, LRNC, and fibrous tissue). Receiver oper-
ating characteristic curve analysis was performed, and the model
was characterized by the area under the receiver operating char-
acteristic curve (Az) with 95%CIs to test the relationship between
HU attenuation values in the ROI and IPH.Moreover, thresholds
derived from theROCanalysis were calculated. TheWilcoxon test
was applied to test the difference of attenuation values before and
after administration of contrast material for the plaques (IPH,
LRNC, and fibrous).
A P value.05 was regarded as indicating a statistically signif-
icant association, and all values were calculated by using a 2-tailed
significance level. R statistical and computing software (www.r-
project.org) was used for statistical analyses.
RESULTS
General Results
The mean time interval between CT and CEA was 9 days (range,
3–14 days). No patients were excluded from the analysis. Twenty-
six cases of IPH were found (prevalence of 23.08%), and another
21 had LRNCwithout IPH (prevalence 23.07%). In 5 cases, along
the length of the plaque, there were histologic slices with LRNC
and other slices with IPH (prevalence of 5.45%). The other 39
plaques did not show IPH or LRNC and were mainly calcified
(n 24) or characterized by fibrous tissue or myofibroblast pro-
liferation (n 15).
In our cohort, we found 29 asymptomatic patients and 62
symptomatic patients. (In the 62 symptomatic patients, 25
strokes, 24 transient ischemic attacks, and 13 cases of amaurosis
fugaxwere observed.) The analysis of the association between IPH
FIG 1. A 67-year-old male patient. The images acquired before (A) and after the administration of contrast material (B) clearly show the carotid
artery plaques. The ROI analyses before (C) and after the administration of contrast material (D) show the HU attenuation of the plaque (13.267
HU and 14.067 HU, respectively). In panel E, the corresponding histologic slice is given.
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and the presence of cerebrovascular symptoms (including the 5
plaques where some histologic slices had LRNC and others had
IPH for a total of 31 subjects with IPH) revealed an association
between plaques with IPH and symptoms with a P value of .02
(17% of IPH in asymptomatic subjects [5/29] and 42% of IPH in
symptomatic subjects [26/62]).
A total of 435 histologic slices were recorded and measured
(the median number for each plaque was 5, ranging from 3–12).
We excluded 61 histologic sections because of suboptimal quality.
Another 129 histologic sections were excluded because they were
mainly calcified plaques, and in another 63 cases, a small amount
of calciumwas found in the histopathologic examinations. There-
fore, 253 histologic sections were excluded.
Radiologists performed the CTmatching in the remaining 182
histologic slices. They excluded 2 patients (with a total of 7 histo-
logic slices) because of streak artifacts and 1 patient who had
movement artifacts (6 histologic slices). The final number of as-
sessed slices was 169 (59 IPH, 63 LRNC, and 47 fibrous).
Plaque Analysis
Table 1 summarizes the results of the attenuation values accord-
ing to the histologic types in the arterial and venous phases. The
average values of the IPH were 17.475 HU and 18.407 HU before
and after the administration of contrast material, respectively.
The average values of the LRNC were 39.476 HU and 48.048 HU
before and after the administration of contrast material, respec-
tively, whereas for the fibrous plaque, the average values were
91.66 HU and 93.128 HU before and after the administration of
contrast material.
We found that the category that showed the bigger enhance-
ment was the LRNC (average increase of 8.54 HU) followed by
fibrous tissue (1.468 HU), whereas the IPH showed the smaller
variation (average increase, 0.932). The concordance between the
readers (measured by Bland-Altman plots) was good, with a sys-
tematic error (1.96 SD) between 2 HU and 3 HU for IPH,
between4 HU and5 HU for LRNC,
and between 6 HU and 12 for fi-
brous tissue.
Mann-Whitney Test
By comparing the attenuation values
among the 3 different analyzed catego-
ries (IPH, LRNC, and fibrous), we found
that there was a statistically significant
difference of HU values both before and
after the administration of contrast ma-
terial (Table 2). In Fig 2 a boxplot shows the attenuation values
according to the category.
Receiver Operating Characteristic Curve Analysis
The receiver operating characteristic curve analysis was per-
formed to test the association between the HU attenuation and
the presence or absence of IPH, shown in Fig 3. The Az for the
attenuation analysis performed in the basal scan was 0.944,
whereas the Az after the administration of contrast medium was
0.978 (difference between the Az; P  .026). From the receiver
operating characteristic curve analysis, we also tested multiple
thresholds to identify the best combination of sensitivity and
specificity value (Table 3). We found that a threshold of 25 HU in
the plaque (in the dataset after administration of contrast mate-
rial) has a sensitivity of 93.22% and a specificity of 92.73% for the
presence of IPH.
Wilcoxon Analysis
This test was used to check the effect of the contrastmaterial in the
plaque categories. By comparing the overall attenuation of the
plaques (IPH, LRNC, and fibrous) before and after the adminis-
tration of contrast medium, we found a statistically significant
difference (P .001). By assessing the attenuation of IPH, LRNC,
and fibrous tissue before and after contrast medium, we found P
values of .006, .0001, and .018, respectively, demonstrating that
the attenuation of the plaque before and after administration of
contrast material is different.
DISCUSSION
Recent published studies have demonstrated that the presence of
IPH is related to an increased risk of stroke independent of the
severity of luminal stenosis.25,26 Therefore, the identification of
IPH represents an important step to correctly stratify the risk of
potential cerebrovascular events of a subject.
CT is a widely used technique for the preoperative assessment
of the subject, which allows for obtaining information related to
other features related to the plaque’s vulnerability such as the
presence of ulcerations or large plaque volume.13,27 It is impor-
tant to remember that because of the radiation delivered, CT is
not considered the best tool for follow-up of patients with carotid
artery stenosis (unlike ultrasound), and that is one of its main
limitations as a diagnostic tool; however, the improvement in CT
technology with the introduction of dose-reduction techniques
results in a viable option. The purpose of this study was to assess
the CT characteristics of IPH with histopathologic correlation to
identify features that allow for confirming or ruling out the IPH.
Table 1: Summary of attenuation values






Fibrous 47 91.66 17.7474 93 47.525–121.400 0.0052
LRNC 63 39.476 19.4529 34 16.075–87.625 0.0355
IPH 59 17.475 4.9283 17 8.975–26.025 0.0668
Contrast
Fibrous 47 93.128 16.3609 94 49.875–120.775 0.0003
LRNC 63 48.048 19.3811 43 21.000–85.925 0.1446
IPH 59 18.407 4.8428 18 10.975–27.000 0.0021
Table 2: Mann-Whitney analysis
Type of Tissue IPH LRNC Fibrous
Basal
IPH x 0.001 0.001
LRNC 0.001 x 0.001
Fibrous 0.001 0.001 x
Contrast
IPH x 0.001 0.001
LRNC 0.001 x 0.001
Fibrous 0.001 0.001 x
Note:—x indicates test is not applicable.
134 Saba Jan 2018 www.ajnr.org
To obtain correct data, our readers (histologists and radiolo-
gists) gave special attention to excluding all those slices or CT
datasets that were not optimal from a technical point of view.
Moreover, the calcified plaques or those plaques with a visible
cluster of calcium were excluded. First, the identification of the
calcium is extremely easy thanks to the big attenuation that this
tissue produces in the x-rays. For the same reason, those histologic
slices where calcium was visible in small amounts were excluded.
From the original 435 histologic slices, radiologists analyzed 169
slices (38.9%).
We found that the average value of
the IPH was extremely low, with an av-
erage basal value of 17.475 HU and av-
erage value of 18.407 HU after the ad-
ministration of contrast medium. In
2009, Adjuk et al28 found that the atten-
uation values of the American Heart As-
sociation plaque VIb (confluent extra-
cellular lipid core complicated by
hemorrhage) was lower compared with
the other types of plaque, with an aver-
age value of 22 HU compared with 59
HU for the other types of plaques, and
these data were confirmed in a further
publication performed by the same
group in 2013.29 Our values are lower
compared with those found by Adjuk et
al,28,29 and we think that this can be at-
tributed to 2 different causes. First, the
different selection criteria; in fact, we ex-
cluded all those plaques that also had a
small cluster of calcium that can justify
the raised attenuation values in the work
of Adjuk et al.28,29 Second, we did not
considered histologic slices with LRNC and IPH, but only those 2
features independently; this approach may explain the lower at-
tenuation values of our observations. In addition, a study pub-
lished by deWeert et al30 in 2006 demonstrated that the presence
of very hypoattenuated areas was associated with the presence of
plaques complicated by hemorrhage (30 HU).
We also compared the attenuation values among the 3 differ-
ent analyzed categories (IPH, LRNC, and fibrous), and we found
that there was a statistically significant difference of HU values
(Table 2). This result demonstrates that the attenuation values are
different from the attenuation of LRNC and fibrous tissue. In
particular, hemorrhage has significantly lower attenuation values
compared with the other categories of tissues.
The receiver operating characteristic curve analysis confirmed
the strength of the association between the hypoattenuated values
and presence of IPH (Az 0.944 in basal analysis and 0.978 after
contrastmedium), and by considering a threshold value of 25HU
(in the scans obtained after the administration of contrast mate-
rial), we obtained a sensitivity of 93.22% and a specificity of
92.73% for the presence of IPH. These results demonstrated that
it is possible to identify an attenuation threshold by identifying
the presence of IPH.
Our results are different from those observed byU-King-Im et
al31 where the authors compared CTA and IPH detected by MR
imaging and found that mean CT plaque attenuation was higher
for plaques with MR imaging–defined IPH (47 HU) compared
with plaques without IPH (43 HU). Moreover, they found a sig-
nificant overlap between the distributions of plaque densities by
concluding that mean plaque attenuation is of limited value in
distinguishing between the 2 groups. The differences between our
results and the paper byU-King-Im et al31 can be explained by the
different methodology applied. They used as reference standard
MR-defined IPH, whereas we considered the histopathologic
FIG 2. Boxplot with the attenuation values before and after the administration of contrast
material according to the type of tissue.
FIG 3. Receiver operating characteristic curve analysis that shows the
Az of the attenuation (basal and after the administration of contrast
medium) versus the presence/absence of IPH.
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slices. We excluded from the analysis all the slices where a cluster
of calcium was identified, and this explains the average lower CT
values found in our study in those plaques with IPH. Moreover,
we considered multiple sections for each plaque according to the
histopathologic category, and this is important because we found
10 plaques where there were areas with IPH and others without
IPH. These findings confirm that in the same plaques, there exist
different tissues, and they are not always represented in a single
axial section. For this reason, we suggest readers check the entire
length of the plaque and not only the thickened point and assess
withROIs having different levels of the plaque. This is a significant
point because the plaques show a spatial heterogeneity other than
a temporal variability; therefore, the plaque should be considered
a dynamic process, and lack of IPH doesn’t mean that sometime
in the future IPH cannot appear.
We also tested the difference in attenuation before and after
the administration of contrast medium and found that there was
a statistically significant difference (.006, .0001, and .018 for IPH,
LRNC, and fibrous tissue, respectively), by confirming the fact
that the contrast material plays an important role in the attenua-
tion values of the carotid artery plaques.32-34
In this study, there are some limitations. First, this is a retro-
spective study, and this approach may determine a bias; however,
it is our opinion this can be a considered a minor limitation be-
cause our focus was to assess the attenuation value of the IPH, and
we would use the same paradigm in prospective approach. Sec-
ond, the registration between histologic sections and the CT da-
taset is fundamental to obtain correct as well as relevant data. We
tried to use our experience and all the potential tools to overcome
the problems related to the registration (spatial registration fea-
tures, manual and experienced correction, and the use of 2 differ-
ent readers). However, there are some limits that are not possible
to solve, in particular, the fact that the histologic preparation leads
to plaque shrinkage35; in the study by de Weert et al,30 the total
plaque area acquired in MDCTA images was 30% larger than the
histologic total plaque area.
CONCLUSIONS
The results of this preliminary study suggest that CT can be used
to identify the presence of IPH according to the attenuation.
A threshold of 25 HU in the volume acquired after the adminis-
tration of contrast medium is associated with an optimal sensitiv-
ity and specificity. Special care should be given to the correct
identification of the area to place the ROI.
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